Universal Cells
Mustafa Serdar Tuncali is a Principal Research Associate at Universal Cells, where Mustafa Serdar is responsible for editing pluripotent stem cells using rAAV technology. Prior to this role, Mustafa Serdar worked as a Senior Research Technologist at Mayo Clinic and held multiple research associate positions at TGen. With a Master's Degree in Clinical Research Management from Arizona State University and a Bachelor's Degree in Pharmacy from Gazi University, Tuncali brings a wealth of experience in laboratory management, drug screening assays, and tissue culture practices in the field of cancer and cell biology.
Universal Cells
Universal Cells is a Seattle-based biotech developing, licensing and commercializing stem cell therapies that overcome immune rejection and can be used to create true off-the-shelf therapeutic products. Using the company's proprietary genome editing approach, the company engineers stem cells to prevent expression of polymorphic human leukocyteantigen (HLA) molecules, removing the cause of donor tissue rejection and creating Universal Donor Stem Cells that are compatible with every patient.